European Organisation for Research and Treatment of Cancer - EORTC: Myelodysplastic Syndromes trials

The registry lists 12 Myelodysplastic Syndromes studies with European Organisation for Research and Treatment of Cancer - EORTC as lead sponsor. 0 are open to participants now and 0 have results posted.

Phase 1 1Phase 2 5Phase 3 6No phase 1(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Empirical Versus Preemptive Antifungal TherapyCompletedNCT01288378Phase 3
• Clofarabine, Cytarabine, and Idarubicin in Treating Patients With Intermediate-Risk or High-Risk Acute Myeloid Leukemia or High-Risk MyelodysplasiaStatus unknownNCT00838240Phase 1/2
• Idarubicin, Cytarabine, and Gemtuzumab Ozogamicin in Treating Patients With Previously Untreated High-Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia Secondary to Myelodysplastic SyndromeCompletedNCT00077116Phase 2
• Infliximab in Treating Patients With Myelodysplastic SyndromeCompletedNCT00074074Phase 2
• Moxifloxacin Compared With Ciprofloxacin/Amoxicillin in Treating Fever and Neutropenia in Patients With CancerTerminatedNCT00062231Not applicable
• Low-Dose Decitabine Compared With Standard Supportive Care in Treating Older Patients With Myelodysplastic SyndromeStatus unknownNCT00043134Phase 3
• Monoclonal Antibody Therapy in Treating Patients With Primary Myelodysplastic SyndromeWithdrawnNCT00003984Phase 2
• Prevention of Infection in Patients With Hematologic Cancer and Persistent Fever Caused by a Low White Blood Cell CountCompletedNCT00003805Phase 3
• Amifostine With or Without Epoetin Alfa in Treating Patients With Myelodysplastic SyndromeStatus unknownNCT00003681Phase 2
• Combination Chemotherapy With or Without Idarubicin and Peripheral Stem Cell Transplantation in Treating Patients With Leukemia or Myelodysplastic SyndromeStatus unknownNCT00002989Phase 3
• Combination Chemotherapy With or Without Peripheral Stem Cell Transplantation in Treating Patients With Myelodysplastic Syndrome or Acute Myelogenous LeukemiaStatus unknownNCT00002926Phase 3
• Combination Chemotherapy in Treating Children With Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic SyndromeCompletedNCT00002517Phase 3